Transcript With the auspices of

Course Venue:
Sala Convegni Polo Le Piagge,
Via Matteotti 11- 56124
Pisa
For registration visit:
http://ems.mzcongressi.com/start/1214/eng
Congress Social Programme
Registration fee includes lunch breaks, coffee breaks
and Farewell Cocktail.
All registered delegates and accompanying persons are
cordially invited to the Welcome Reception on Friday
4th November 2016. Welcome reception tickets will be
available upon reservation by October 23, at € 30.
Special thanks to:
With the auspices of
Scientific Committe
Paola Anna Erba, MD, PhD
Department of Translational Research and New Technology
in Medicine, University of Pisa
[email protected]
Lorenzo Mannelli, MD, PhD
Memorial Sloan Kettering Cancer Center New York
[email protected]
Friday 4th November 2016
8.30
9.00
Registration
Welcome and Introduction
Wonders of Nature: Hybrids, Monsters and Prodigies in
XV-XVII centuries in Europe. L. Tongiorgi, University of
Pisa
Uterus & Ovary
16.30
16.50
17.10
Lung & mediastinum
10.00
10.20
10.40
11.00
Screening and Diagnosis. Mario Mascalchi, University of
Florence
Radiologic Pathologic Correlations in Thoracic Neoplsia.
M.S. Ginsberg, MSKCC New York
Imaging of Complications of Cancer and Its Therapy in
the Thorax. M.S. Ginsberg, MSKCC New York
Read with the expert . R. Delgado Bolton, San Pedro
Hospital and Centre for Biomedical Research of La Rioja, Logrono
Coffee break
11.40
12.00
12.20
12.40
Differential diagnosis of mediastinal lesions L. Saba,
University of Cagliari
Post Radiation Therapy Lung Imaging M.S. Ginsberg,
MSKCC New York
Read with the expert L. Saba, University of Cagliari
Discussion
Lunch break
Liver & Pancreas-hepatobilliary, colorectal
14.00
14.20
14.40
15.00
15.20
15.40
Focal liver lesions: how to differentiate between benign
and malignant lesions? C. Bartolozzi, University of Pisa
Hepatocellular Carcinoma: a practical approach to multimodality imaging. D. Marin, Dukes University
LI-RADS and the management of hepatocellular carcinoma. D. Marin, Dukes University
Metastatic liver disease: the importance of hybrid imaging. L. Mannelli, MSKCC New York
Criteria-based reporting for assessing treatment response in liver cancer, pearls and pitfalls on imaging. D.
Marin, Dukes University
Read with the expert. L. Mannelli, MSKCC New York
Coffee break
17.30
17.50
18.10
18.30
Incidental cystic lesions of the pancreas: impact of
clinical management. E. Godfrey, St Catharine's
College, Cambridge
Pancreatic cancer staging: which role for multimodal
imaging? L. Mannelli, MSKCC New York
Criteria-based reporting for assessing treatment
response in pancreatic cancer, pearls and pitfalls on
imaging. E. Boninsegna, University of Verona
The many faces of Cholangiocarcinoma. D. Marin,
Dukes University
Colon cancer: when and why go hybrid - A. Soricelli,
University of Naples
Read with the expert. E. Boninsegna, University of
Verona
Discussion
10.50
11.10
11.30
11.50
12.10
12.30
12.50
Staging Ovarian Cancer - providing a GPS to
management. E. Sala, MSKCC New York
Differentiating benign from malignant disease: how and
when not to sit on the fence. E. Sala, MSKCC New York
Criteria-based reporting for assessing treatment
response in ovarian cancer, pearls and pitfalls on
imaging. S. Magnaldi. U.O. Radiologia Fondazione
Poliambulanza Istituto Ospedaliero, Brescia
How does imaging direct management in patients with
uterine malignancies. E. Sala, MSKCC New York
Read with the expert. S. Magnaldi. U.O. Radiologia
Fondazione Poliambulanza Istituto Ospedaliero, Brescia
Discussion
MCQs
Lunch break and closure of the course
Welcome reception
Saturday 5th November 2016
Criteria-based reporting for assessing
treatment response
8.30
8.50
9.10
9.30
9.50
10.10
RECIST and PERCIST - a comparison of their usefulness
for measuring treatment response. H. Schoder,
MSKCC New York
Cancer specific treatment response criteria:
lymphoma. M. Meignan, Creteil
Assessment of bone response to anticancer
treatment. L.M. Scofienza, University of Milan
Cancer specific treatment response criteria: Multiple
Myeloma. G. Masselli, Università La Sapienza, Rome
Read with the expert L.M. Scofienza, University of
Milan
Discussion
Prostate Cancer Mini-symposium
14.00 Imaging Prostate Cancer in 2016. S. Fanti, University of
Bologna
14.20 MRI for the initial assessment of patients with suspected
or newly diagnosed prostate cancer H.A. Vargas, MSKCC
New York
14.40 Hybrid imaging for staging prostate cancer. H. Schoder,
MSKCC New York
15.00 Imaging Recurrent prostate cancer with MRI: why, when
and how. H.A. Vargas, MSKCC New York
15.20 Imaging treated prostate cancer: how hybrid imaging
change the paradigm. A. Chiti, Humanitas University,
Milan
15.40 Read with the expert: What we learned from the project
Biomarkers And Functional Imaging Guided Treatment
Decision Making In Recurrent Prostate Cancer (Progetto di
Ricerca Giovani Ricercatori - Ricerca Finalizzata 2010). P.A.
Erba, University of Pisa
16.00 Discussion
Coffee break
16.30 Meet the Professor: Molecular Imaging in Prostate
Cancer: Enhancing the image - new strategies. H. Schoder,
MSKCC New York
Closing remarks
Farewell Cocktail